Hypertension in the Parsi community of Bombay: a study on prevalence, awareness and compliance to treatment

Bharucha, Nadir E.; Kuruvilla, Thomas
January 2003
BMC Public Health;2003, Vol. 3, p1
Academic Journal
Background: Uncontrolled hypertension (HT) is an established risk factor for the development of vascular diseases. Prevalence varies in different communities and no such study has been conducted in the Parsi community living in Bombay, India. The objectives of this study were to determine the prevalence, awareness, compliance to medication and control of HT in this community. Method: We used a 1 in 4 random selection of subjects who were ≥ 20 years of age. A questionnaire was administered and the blood pressure (BP) was measured by a doctor. HT was defined as diastolic blood pressure (DBP) ≥ 90 mm Hg ± systolic pressure (SBP) ≥ 140 mm Hg. Isolated systolic hypertension (ISH) was defined as SBP ≥ 160 mm Hg with DBP < 90 mm Hg. Subsequently, we reanalysed the data using current definition of ISH as SBP ≥ 140 mm Hg with DBP < 90 mm Hg. Results: 2879 subjects ≥ 20 years of age were randomly selected of which 2415 (84%) participated in the study. The overall prevalence of HT in the community was 36.4%, of whom 48.5% were unaware of their hypertensive status. Of those aware of having HT, 36.4% were non-compliant with their anti-hypertensive drugs and only 13.6% had optimally controlled HT. Prevalence of ISH using the present criteria was 19.5% and 73% of hypertensives ≥ 60 years had ISH. Conclusion: This study shows that prevalence of HT in the Parsi community is high and nearly half are unaware of their hypertensive status. ISH is the dominant form of HT in the elderly. Compliance to treatment is poor and optimal BP control is achieved in only a small minority. The study highlights the need for regular screening coupled with educational programs to detect and optimally treat HT in the community.


Related Articles

  • Experiences of Telemedicine-Aided Hypertension Control in the Follow-Up of Finnish Hypertensive Patients. Juha Varis; Sampo Karjalainen; Krista Korhonen; Margus Viigimaa; Kristjan Port; Ilkka Kantola // Telemedicine & e-Health;Oct2009, Vol. 15 Issue 8, p764 

    The prevalence of hypertension is high in Finland. Only one fourth of the drug-treated hypertensive patients reach their target pressure. We evaluated a commercially available telemedicine system for impact in reaching better blood pressure control among Finnish hypertensive patients. A...

  • Variability in Antihypertensive Drug Therapy and Compliance: Results from a Random Survey in the United Arab Emirates. Sulaiman, Syed Azhar Syed; Alomar, Muaed Jamal; Strauch, Claire Caroline // American Journal of Pharmacology & Toxicology;2009, Vol. 4 Issue 3, p38 

    Problem statement: Hypertension is one of the most common diseases known as the 'silent killer' because it shows no clinical signs and symptoms. The high prevalence of hypertension in the United Arab Emirates stresses the importance to initiate a nation-wide effort to prevent and control high...

  • Adesão ao tratamento medicamentoso em usuários cadastrados no Programa Hiperdia no município de Teresina (PI). Menezes Carvalho, Andre Luis; Duarte Leopoldino, Ramon Weyler; da Silva, Jose Eduardo Gomes; da Cunha, Clemilton Pereira // Revista Ciência & Saúde Coletiva;jul2012, Vol. 17 Issue 7, p1885 

    Arterial hypertension and diabetes mellitus are among the most chronic diseases prevalent in Brazil. The study sought to evaluate the socioeconomic profile and the therapeutic adherence of users registered in the HIPERDIA Program in Teresina in the State of Piauí. This research was conducted...

  • PREVALENCE, AWARENESS, TREATMENT AND CONTROL OF HYPERTENSION AMONG THE PEOPLE ABOVE 15 YEARS IN RURAL AREA NAGPUR MAHARASHTRA - A CROSS SECTIONAL STUDY. Bhardwaj, Sumit D.; Sinha, Umesh; Shewte, Mamta K.; Khadse, Jyoti R.; Bhatkule, Prakash R. // National Journal of Community Medicine;Apr-Jun2012, Vol. 3 Issue 2, p213 

    Introduction: High blood pressure (BP) is a major risk factor for cardiovascular disease and better control can lead to prevention of 300,000 of the 1.5 million annual deaths from cardiovascular diseases in India. Objective: - To evaluate the prevalence, awareness, treatment and control of...

  • Single Sevikar®: Combination Therapy for the Treatment of Hypertension. Pimenta, Eduardo // Clinical Medicine: Therapeutics;2009, Issue 1, p703 

    Hypertension is one of the most important modifiable risk factor for cardiovascular morbidity and mortality and is highly prevalent. Recent guidelines and advisory statements have recommended lower thresholds and goals for patients with hypertension. However, approximately two-thirds of...

  • Therapeutic Options for the Treatment of Hypertension in Children and Adolescents. Stephens, Mary M.; Fox, Beth A.; Maxwell, Lisa // Clinical Medicine Insights: Circulatory, Respiratory & Pulmonary;2012, Issue 6, p13 

    Primary hypertension in children is increasing in prevalence with many cases likely going undiagnosed. The prevalence is currently estimated at between 3%-5% in the United States and may be higher in certain ethnic groups. Primary hypertension, once felt to be rare in children, is now considered...


    Chapter 70 of the book "Advanced Therapy in Hypertension and Vascular Disease" is presented. It discusses drug adherence of patients with hypertension. The consequences of poor adherence by hypertensive patients to long-term therapies are mentioned. It also explores the economic consequences of...

  • A systematic review of patient information leaflets for hypertension. Fitzmaurice, D A; Adams, J L // Journal of Human Hypertension;Apr2000, Vol. 14 Issue 4, p259 

    Objective: To review patient information leaflets on hypertension to determine the quality of information currently available to patients. Design and setting: A standardised systematic rating of patient information leaflets for hypertension in the UK. Main outcome measure: A quality score per...

  • The COMpliance PraxiS Survey (COMPASS): a multidimensional instrument to monitor compliance for patients on antihypertensive medication. Schoberberger, R; Janda, M; Pescosta, W; Sonneck, G // Journal of Human Hypertension;Nov2002, Vol. 16 Issue 11, p779 

    Low compliance is suspected as a major reason for treatment failure in hypertensive patients. To identify patients with low compliance at the commencement of antihypertensive treatment, the compliance praxis survey (COMPASS) was utilised. A total of 161 physicians identified 2389 hypertensive...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics